GemPharmatech Hits Day Low of CNY 14.89 Amid Price Pressure

GemPharmatech Co., Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, experienced a significant decline today, with its stock price dropping by 8.76% on March 3, 2026. The stock reached an intraday low of CNY 14.89, reflecting ongoing challenges in its performance metrics. Over the past week, GemPharmatech has seen a decrease of 11.82%, and its monthly performance stands at a decline of 13.39%. Year-to-date, the stock has lost 2.34%, contrasting sharply with the China Shanghai Composite, which has gained 2.85% during the same period. The company's performance over the last three years has been particularly concerning, with a staggering decline of 44.65%. Financially, GemPharmatech has reported negative results for five consecutive quarters, with operating cash flow at its lowest point of CNY 97.58 million. The company's return on equity is at 4.80%, and it has a price-to-book ratio of 1.73. Despite generating a return of 6.13% over the past year, this figure falls significantly short of the broader market's performance, which has seen returns of 22.49%.